Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryoko Yamazawa

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Neuropsychopharmacology Reports|June 4, 2020
Gap between patients with schizophrenia and their psychiatrists on the needs to psychopharmacological treatment: A cross-sectional studyKie Takahashi, Ryoko Yamazawa, Takefumi Suzuki, et al.
The Australian and New Zealand Journal of Psychiatry|January 17, 2008
Association between duration of untreated psychosis, premorbid functioning, and cognitive performance and the outcome of first-episode schizophrenia in Japanese patients: prospective studyRyoko Yamazawa, Takahiro Nemoto, Hiroyuki Kobayashi, et al.
Early Intervention in Psychiatry|June 12, 2010
Clinical and social determinants of a longer duration of untreated psychosis of schizophrenia in a Japanese populationHerbert Nishii, Ryoko Yamazawa, Shinji Shimodera, et al.
Early Intervention in Psychiatry|August 18, 2010
Correlation between attenuated psychotic experiences and depressive symptoms among Japanese studentsHiroyuki Kobayashi, Ryoko Yamazawa, Takahiro Nemoto, et al.
Psychiatry and Clinical Neurosciences|December 18, 2003
Duration of untreated psychosis and pathways to psychiatric services in first-episode schizophreniaRyoko Yamazawa, Masafumi Mizuno, Takahiro Nemoto, et al.
Journal of Clinical Psychopharmacology|September 12, 2009
Effects of aripiprazole on insight and subjective experience in individuals with an at-risk mental stateHiroyuki Kobayashi, Keiko Morita, Kiyoaki Takeshi, et al.
Asian Journal of Psychiatry|March 17, 2018
Is it possible to implement community care based on mental health in Japan? A comparison between decade ago and present on Duration of Untreated Psychosis (DUP)Kouta Suzuki, Hidehito Niimura, Ryoko Yamazawa, et al.
Schizophrenia Research|September 24, 2008
A self-reported instrument for prodromal symptoms of psychosis: testing the clinical validity of the PRIME Screen-Revised (PS-R) in a Japanese populationHiroyuki Kobayashi, Takahiro Nemoto, Hiroki Koshikawa, et al.
Psychiatry and Clinical Neurosciences|August 20, 2011
Successful aging in individuals with schizophrenia dwelling in the community: a study on attitudes toward aging and preparing behavior for old ageHidehito Niimura, Takahiro Nemoto, Ryoko Yamazawa, et al.
Journal of Clinical Psychopharmacology|January 18, 2006
Reducing the dose of antipsychotic agents ameliorates visual hypersensitivity attack: an ideal treatment option in terms of the adverse effectHiroyuki Uchida, Takefumi Suzuki, Ryoko Yamazawa, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Neuropsychopharmacology Reports|June 4, 2020
Gap between patients with schizophrenia and their psychiatrists on the needs to psychopharmacological treatment: A cross-sectional studyKie Takahashi, Ryoko Yamazawa, Takefumi Suzuki, et al.
The Australian and New Zealand Journal of Psychiatry|January 17, 2008
Association between duration of untreated psychosis, premorbid functioning, and cognitive performance and the outcome of first-episode schizophrenia in Japanese patients: prospective studyRyoko Yamazawa, Takahiro Nemoto, Hiroyuki Kobayashi, et al.
Early Intervention in Psychiatry|June 12, 2010
Clinical and social determinants of a longer duration of untreated psychosis of schizophrenia in a Japanese populationHerbert Nishii, Ryoko Yamazawa, Shinji Shimodera, et al.
Early Intervention in Psychiatry|August 18, 2010
Correlation between attenuated psychotic experiences and depressive symptoms among Japanese studentsHiroyuki Kobayashi, Ryoko Yamazawa, Takahiro Nemoto, et al.
Psychiatry and Clinical Neurosciences|December 18, 2003
Duration of untreated psychosis and pathways to psychiatric services in first-episode schizophreniaRyoko Yamazawa, Masafumi Mizuno, Takahiro Nemoto, et al.
Journal of Clinical Psychopharmacology|September 12, 2009
Effects of aripiprazole on insight and subjective experience in individuals with an at-risk mental stateHiroyuki Kobayashi, Keiko Morita, Kiyoaki Takeshi, et al.
Asian Journal of Psychiatry|March 17, 2018
Is it possible to implement community care based on mental health in Japan? A comparison between decade ago and present on Duration of Untreated Psychosis (DUP)Kouta Suzuki, Hidehito Niimura, Ryoko Yamazawa, et al.
Schizophrenia Research|September 24, 2008
A self-reported instrument for prodromal symptoms of psychosis: testing the clinical validity of the PRIME Screen-Revised (PS-R) in a Japanese populationHiroyuki Kobayashi, Takahiro Nemoto, Hiroki Koshikawa, et al.
Psychiatry and Clinical Neurosciences|August 20, 2011
Successful aging in individuals with schizophrenia dwelling in the community: a study on attitudes toward aging and preparing behavior for old ageHidehito Niimura, Takahiro Nemoto, Ryoko Yamazawa, et al.
Journal of Clinical Psychopharmacology|January 18, 2006
Reducing the dose of antipsychotic agents ameliorates visual hypersensitivity attack: an ideal treatment option in terms of the adverse effectHiroyuki Uchida, Takefumi Suzuki, Ryoko Yamazawa, et al.
Pageof 2